Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Esophageal × nimotuzumab × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Squamous Cell Carcinoma 11 Esophageal Neoplasms 11 Pancreatic Neoplasms 8 Stomach Neoplasms 3 Pancreatic cancer, adult 2 Colorectal Neoplasms 2 Squamous Cell Carcinoma of Anal Canal 1 Resectable Pancreatic Cancer 1 Pancreatic Cancer Resectable 1 Neoplasm Metastasis 1 Esophageal 1 Advanced Pancreatic Cancer 1 Advanced Esophageal 1 Advanced Colorectal Cancer 1 Adenocarcinoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00950417 2015-08-19

Nimotuzumab in Combination With Chemoradiation for Esophageal Cancer

Biotech Pharmaceutical Co., Ltd.

Phase 1 Completed

Gastrointestinal

Advanced Esophageal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡